Remdesivir Works Best in COVID Patients on Oxygen: NIH Trial Remdesivir Works Best in COVID Patients on Oxygen: NIH Trial

The U.S. National Institutes of Health (NIH) on Friday said that data from its trial of Gilead Sciences Inc ’ s remdesivir show that the drug offers the most benefit for COVID-19 patients who need extra oxygen but do not require mechanical ventilation.Reuters Health Information
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news